- Home
- CLMB vs DNTH Comparison
CLMB vs DNTH Comparison
Compare CLMB & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLMB
- DNTH
- Stock Information
- Founded
- CLMB 1982
- DNTH 2015
- Country
- CLMB United States
- DNTH United States
- Employees
- CLMB N/A
- DNTH N/A
- Industry
- CLMB Retail: Computer Software & Peripheral Equipment
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- CLMB Technology
- DNTH Health Care
- Exchange
- CLMB Nasdaq
- DNTH Nasdaq
- Market Cap
- CLMB 489.1M
- DNTH 568.6M
- IPO Year
- CLMB N/A
- DNTH N/A
- Fundamental
- Price
- CLMB $99.69
- DNTH $16.86
- Analyst Decision
- CLMB Buy
- DNTH Strong Buy
- Analyst Count
- CLMB 1
- DNTH 8
- Target Price
- CLMB $136.00
- DNTH $53.00
- AVG Volume (30 Days)
- CLMB 106.6K
- DNTH 261.3K
- Earning Date
- CLMB 08-05-2025
- DNTH 08-07-2025
- Dividend Yield
- CLMB 0.68%
- DNTH N/A
- EPS Growth
- CLMB 65.26
- DNTH N/A
- EPS
- CLMB 4.26
- DNTH N/A
- Revenue
- CLMB $511,229,000.00
- DNTH $6,524,000.00
- Revenue This Year
- CLMB $19.60
- DNTH N/A
- Revenue Next Year
- CLMB $8.00
- DNTH N/A
- P/E Ratio
- CLMB $23.36
- DNTH N/A
- Revenue Growth
- CLMB 42.25
- DNTH 102.36
- 52 Week Low
- CLMB $54.91
- DNTH $13.37
- 52 Week High
- CLMB $145.00
- DNTH $32.27
- Technical
- Relative Strength Index (RSI)
- CLMB 36.07
- DNTH 38.63
- Support Level
- CLMB $103.00
- DNTH $17.67
- Resistance Level
- CLMB $108.39
- DNTH $19.58
- Average True Range (ATR)
- CLMB 3.38
- DNTH 1.14
- MACD
- CLMB -0.45
- DNTH -0.07
- Stochastic Oscillator
- CLMB 11.69
- DNTH 3.20
About CLMB Climb Global Solutions Inc.
Climb Global Solutions Inc is a cloud-based, value-added IT distribution and solutions company specializing in emerging technologies. It operates across the USA, Canada, and Europe through multiple business units, including Climb Channel Solutions, Sigma, Grey Matter, Interwork, and TechXtend. The company is organized into two reportable operating segments. The Distribution segment distributes technical software to corporate resellers, value-added resellers (VARs), consultants, and systems integrators under the name Climb Channel Solutions. The Solutions segment is a cloud solutions provider and value-added reseller of software, hardware, and services to customers under the name Grey Matter.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.